Sofosvel a Project of Reinforce Lab
Sofosvel is the global first generic oral tablet for pan-genotypic Chronic Hepatitis C treatment manufactured by Beacon Pharmaceuticals Limited.

Project Description

Sofosvel is the global first generic oral tablet for pan-genotypic Chronic Hepatitis C treatment manufactured by Beacon Pharmaceuticals Limited. This combination (Sofosbuvir 400 mg + Valpatasvir 100 mg) drug has been approved by US FDA & European Commission for treatment of patients with all genotypic Chronic Hepatitis C virus infection. Sofosvel is used without cirrhosis or with compensated cirrhosis, and patients with advanced cirrhosis (Decompensated).

We have ensured best quality design for the website to make it user friendly for the customers. We have also set several call action to increase the sales rate of the product’s website.

Project Details

Client: Beacon Pharmaceuticals Limited
Date: 27.07.2016
Skills: Branding, Web Design, Hepatitis C Product’s Website
View: http://www.sofosvel.com

Like What You See?

Years in Business

Companies Served

%

Satisfied Clients

Get In Touch

+880 131 3450 777

Address

Suite: 601, Level: 6,
Concord Tower, 113 Kazi Nazrul Islam Avenue, Dhaka-1000, Bangladesh.

Email

hello@reinforcelab.com
service@reinforcelab.com
support@reinforcelab.com

Open Hours

Saturday – Thursday : 10am – 6pm,
Friday: Closed

Send A Message

0/5 (0 Reviews)

Pin It on Pinterest

Share This